Literature DB >> 23869780

Effects of limonoid cedrelone on MDA-MB-231 breast tumor cells in vitro.

Angelina M Fuzer, Júlio César C Filho, Amanda B Becceneri, Damiana A Dos Santos, Maria Fátima das G F da Silva, Paulo C Vieira, João B Fernandes, Heloisa S Selistre-de-Araujo, Cristiane M Cazal, Márcia R Cominetti1.   

Abstract

Cancer is the second leading cause of death, preceded only by cardiovascular diseases, and there is epidemiological evidence that demonstrate this tendency is emerging worldwide. Brazil has an extensive vegetal biodiversity with more than 55,000 species listed. Such biodiversity collaborates with the finding of compounds which could be the basis for the design of new anti-tumor drugs, with fewer side effects than the conventional chemotherapy used currently. Cedrelone is a limonoid isolated from Trichilia catigua (Meliaceae) which is a native Brazilian plant. This study demonstrates that cedrelone inhibits proliferation, adhesion, migration and invasion of breast tumor cells from the line MDA-MB-231. The effects of cell migration and invasion on MDA-MB-231 cell may be explained, at least in part, by the ability of cedrelone to inhibit MMP activity. We also demonstrate that cedrelone is able to induce apoptosis in MDA-MB-231 cells. There are only a few works investigating the effect of limonoids in cellular processes closely related to tumor progression such as adhesion, migration and invasion. To the best of our knowledge, this is the first work describing the effects of a limonoid on tumor and non-tumor cell adhesion process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23869780     DOI: 10.2174/18715206113139990314

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  2 in total

1.  Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1.

Authors:  Jiansong Wu; Qiang Niu; Jie Yuan; Xiaodan Xu; Liuxia Cao
Journal:  Exp Ther Med       Date:  2019-10-07       Impact factor: 2.447

2.  Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.

Authors:  Cecília P Popolin; João P B Reis; Amanda B Becceneri; Angélica E Graminha; Márcio A P Almeida; Rodrigo S Corrêa; Legna A Colina-Vegas; Javier Ellena; Alzir A Batista; Márcia R Cominetti
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.